Additionally, immune-cell-derived IL-17 can regulate the stem cell features of pancreatic cancer cells, leading to the increased expression of DCLK1, POU2F3, ALDH1A1, and IL-17RC [86]. The gene discussed is IL17A; the disease is pancreatic neoplasm.